Mitochondrial transfer from induced pluripotent stem cells rescues developmental potential of in vitro fertilized embryos from aging females†
C Zhang, L Tao, Y Yue, L Ren, Z Zhang… - Biology of …, 2021 - academic.oup.com
Conventional heterologous mitochondrial replacement therapy is clinically complicated by
“tri-parental” ethical concerns and limited source of healthy donor oocytes or zygotes …
“tri-parental” ethical concerns and limited source of healthy donor oocytes or zygotes …
Mitochondrial transfer from induced pluripotent stem cells rescues developmental potential of in vitro fertilized embryos from aging females†
C Zhang, T Li, Y Yuan, L Ren, Z Zhang… - Biology of …, 2021 - search.proquest.com
Conventional heterologous mitochondrial replacement therapy is clinically complicated by
“tri-parental” ethical concerns and limited source of healthy donor oocytes or zygotes …
“tri-parental” ethical concerns and limited source of healthy donor oocytes or zygotes …
Mitochondrial transfer from induced pluripotent stem cells rescues developmental potential of in vitro fertilized embryos from aging females
C Zhang, L Tao, Y Yue, L Ren, Z Zhang, X Wang… - Biology of …, 2021 - BioOne
Conventional heterologous mitochondrial replacement therapy is clinically complicated by
“triparental” ethical concerns and limited source of healthy donor oocytes or zygotes …
“triparental” ethical concerns and limited source of healthy donor oocytes or zygotes …
Mitochondrial transfer from induced pluripotent stem cells rescues developmental potential of in vitro fertilized embryos from aging females
C Zhang, L Tao, Y Yue, L Ren… - Biology of …, 2021 - pubmed.ncbi.nlm.nih.gov
Conventional heterologous mitochondrial replacement therapy is clinically complicated by"
tri-parental" ethical concerns and limited source of healthy donor oocytes or zygotes …
tri-parental" ethical concerns and limited source of healthy donor oocytes or zygotes …
Mitochondrial transfer from induced pluripotent stem cells rescues developmental potential of in vitro fertilized embryos from aging females†
C Zhang, L Tao, Y Yue, L Ren, Z Zhang… - Biology of …, 2021 - academic.oup.com
Conventional heterologous mitochondrial replacement therapy is clinically complicated by
“tri-parental” ethical concerns and limited source of healthy donor oocytes or zygotes …
“tri-parental” ethical concerns and limited source of healthy donor oocytes or zygotes …
Mitochondrial transfer from induced pluripotent stem cells rescues developmental potential of in vitro fertilized embryos from aging females
C Zhang, L Tao, Y Yue, L Ren, Z Zhang, X Wang… - Biology of …, 2021 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: p> Conventional heterologous mitochondrial
replacement therapy is clinically complicated by “tri-parental” ethical concerns and limited …
replacement therapy is clinically complicated by “tri-parental” ethical concerns and limited …
Mitochondrial transfer from induced pluripotent stem cells rescues developmental potential of in vitro fertilized embryos from aging females†.
C Zhang, L Tao, Y Yue, L Ren, Z Zhang… - Biology of …, 2021 - europepmc.org
Conventional heterologous mitochondrial replacement therapy is clinically complicated by"
tri-parental" ethical concerns and limited source of healthy donor oocytes or zygotes …
tri-parental" ethical concerns and limited source of healthy donor oocytes or zygotes …
Mitochondrial transfer from induced pluripotent stem cells rescues developmental potential of in vitro fertilized embryos from aging females
C Zhang, L Tao, Y Yue, L Ren, Z Zhang, X Wang… - Biology of …, 2021 - BioOne
Conventional heterologous mitochondrial replacement therapy is clinically complicated by
“triparental” ethical concerns and limited source of healthy donor oocytes or zygotes …
“triparental” ethical concerns and limited source of healthy donor oocytes or zygotes …